Injectable flu drug could add to weapons against infection

WASHINGTON — A single injection of an experimental flu drug can curtail symptoms of the disease, researchers report. The therapeutic shot, which inhibits the viral protein neuraminidase, is already approved for use in Japan and South Korea, and researchers hope the new findings will speed its approval in the United States.